Eva Pålsson-McDermott and Luke O’Neill at Trinity College Dublin examine targeting immunometabolism as an anti-inflammation tactic. They initially evaluate metabolic therapies with anti-inflammatory outcomes, and after that target glycolysis and the TCA cycle to establish the concept of targeting metabolic intermediates and enzymes in inflammation.7 Moreover immunometabolism, inflamma... https://directivepublications.org/journal-of-immunology/